Trailing-twelve-month (TTM) revenue is $249.14 Million with a year-over-year growth of +178.20%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $2,500,007 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-13 |
| Q4 FY2025Period ended 2025-12-31 | $82,980,503 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-16 |
| Q1 FY2026Period ended 2026-03-31 | $79,728,780 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-11 |
| Q2 FY2026Period ended 2026-06-30 | $83,926,048 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-10 |
| TTM revenue | $249,135,338 |
Current P/S: $202,988,312 market capitalization ÷ $249,135,338 TTM revenue = 0.81x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T19:15:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $83.93M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T19:18:32.815Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20172017-12-31 · USD | FY20182018-12-31 · USD | FY20192019-12-31 · USD | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Cemetery and Mortuary | N/A | N/A | N/A | $20M | $28M | N/A |
| Consolidated | N/A | N/A |
$249.14M
$249.14 Million
+178.20%
vs. $89.55M a year ago (TTM)
+155.01%
5 Year compound annual growth rate
1 Year
+178.20%
3 Year
+29.24%
5 Year
+155.01%
10 Year
N/A
15 Year
+14.16%
20 Year
+4.60%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $344.59M | +$336.40M | +4106.21% |
| 2024 | $8.19M | ($1.36M) | (14.20%) |
| 2023 | $9.55M | ($118,408) | (1.22%) |
| 2022 | $9.67M | +$280,680 | +2.99% |
| 2021 | $9.39M | ($135.66M) | (93.53%) |
| 2003 |
TTM Growth
+178.20%
3-Year CAGR
+29.24%
5-Year CAGR
+155.01%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 26 comparable quarters.
| N/A |
| $412M |
| $471M |
| N/A |
| Contractual Servicing Fees | $7M | $8M | $7M | N/A | N/A | N/A |
|---|
| Intercompany Eliminations | N/A | N/A | N/A | $0 | -$8M | N/A |
|---|
| Late fees | $284,550 | N/A | N/A | N/A | N/A | N/A |
|---|
| Late Fees | N/A | $319,244 | $365,477 | N/A | N/A | N/A |
|---|
| Life Insurance | N/A | N/A | N/A | N/A | N/A | $208M |
|---|
| Life Insurance Product Line | N/A | N/A | N/A | $93M | N/A | N/A |
|---|
| Life Insurance Segments | N/A | N/A | N/A | N/A | $171M | N/A |
|---|
| Mortgage | N/A | N/A | N/A | $299M | $281M | $110M |
|---|
| $145.04M |
| +$112.23M |
| +341.95% |
| 1998 | $32.82M | +$4.34M | +15.26% |
| 1997 | $28.47M | ($1.45M) | (4.84%) |
